WS #11552

From 500 msgs · 5 key-dev

Vertex Pharmaceuticals agrees to acquire Crinetics Pharmaceuticals for $85/share in cash, a significant biotech M&A event.

Vertex Acquires Crinetics Pharmaceuticals

Vertex Pharmaceuticals agrees to acquire Crinetics Pharmaceuticals for $85/share in cash, a significant biotech M&A event.

Full world state #11552 →